Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
1,001	33.67798	1	female	1	26	26	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	null	0	758,539	233,276	234,875	49.5	black	35.796875	58	0.658936	0.560913	14	0	0	no	0.8	0.8	no dnr	26	118	13.298828	105	36	37.79688	255	null	16.796875	3.899902	147	7.469727	350	66	3,025	null	0	<2 mo. follow-up	0
1,002	71.29095	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	117,388	42,800.4062	44,380.125	60	black	32.695313	59	0.588989	0.47998	2	1	0	no	0.5	0.5	no dnr	5	55	11.898438	100	32	38.39844	131.65625	null	null	7.5	146	7.449219	199	65	753	null	null	<2 mo. follow-up	2.475098
1,003	59.452	1	female	0	7	756	Colon Cancer	Cancer	1	12	null	0	27,070	null	null	10.5	white	13.798828	5	0.863892	0.695923	1	0	0	metastatic	1	0.5	no dnr	7	97	9.599609	74	20	38.89844	null	null	null	1	135	null	null	13	2,025	0	2	no(M2 and SIP pres)	2
1,004	74.97894	1	female	1	4	4	MOSF w/Malig	ARF/MOSF	1	18	$25-$50k	37	60,987	21,162.5156	28,040.5469	52	white	54.59375	86	0	0	5	0	0	metastatic	0.2	0.05	dnr after sadm	4	42	13.099609	105	25	35.5	121.65625	3.299805	20	2.299805	135	7.489258	178	21	18	null	2	<2 mo. follow-up	2
1,005	75.67999	1	male	1	20	20	MOSF w/Malig	ARF/MOSF	1	16	$25-$50k	26	122,270	41,109.0312	64,786.375	30.666656	white	29.898438	47	0.299988	0.188995	11	0	0	yes	0.65	0.25	dnr after sadm	6	115	0.299988	120	6	37.79688	205	null	null	1.599854	140	7.5	183	29	3,102	null	0	<2 mo. follow-up	0
1,006	65.26196	0	female	0	14	929	Lung Cancer	Cancer	1	12	>$50k	0	35,260	17,061.2188	17,638.6094	11.666664	white	7.699219	10	0.849976	0.667969	1	0	0	metastatic	null	null	no dnr	14	115	10.5	100	20	39	null	4.199219	0.299988	1	139	null	91	13	2,050	1	1	no(M2 and SIP pres)	1
1,007	65.74896	1	female	0	10	689	CHF	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	34,253	17,195.6094	23,903.0781	25.5	white	20.296875	17	0.856934	0.762939	1	0	0	no	0.65	0.5	no dnr	10	62	10.298828	70	22	36.19531	null	3.299805	1.899902	1.299805	132	null	119	17	5,395	5	null	null	3.854981
1,008	75.97296	1	male	0	13	591	CHF	COPD/CHF/Cirrhosis	2	16	$25-$50k	0	51,180	24,631.8281	22,223.6875	17	white	21.796875	41	0.803955	0.682983	1	0	0	no	0.8	0.6	no dnr	13	68	13.398438	70	22	39	null	null	null	4	142	null	150	34	50	3	3	null	3
1,009	72.33899	0	female	0	23	923	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	37	146,792	47,670.3125	73,489.0625	24.333328	white	17.398438	19	0.740967	0.659912	5	0	0	no	0.95	0.9	no dnr	23	132	19.296875	75	16	37.69531	293.875	null	null	0.599976	135	7.389648	149	18	1,615	null	1	null	1
1,010	70.62299	1	male	0	15	44	Lung Cancer	Cancer	1	12	$25-$50k	0	48,292	20,661.4688	23,549.2656	15.333328	white	25	15	0.496948	0.176971	1	0	0	metastatic	0.6	0.2	no dnr	15	93	25.097656	104	20	36.59375	null	3.299805	0.299988	1.299805	129	null	148	19	3,250	0	0	<2 mo. follow-up	0
1,011	61.80698	1	female	0	9	566	COPD	COPD/CHF/Cirrhosis	2	20	>$50k	0	17,086	10,877.5703	10,449.0938	16	white	22.796875	25	0.81189	0.695923	1	0	0	yes	0.8	0.6	no dnr	9	73	10.099609	102	32	35.79688	266.625	null	null	1	131	7.389648	null	17	2,400	1	0	null	0
1,012	68.758	1	female	0	9	371	Colon Cancer	Cancer	1	16	null	0	24,338	13,225.6875	13,138.7891	19	white	18.296875	25	0.790894	0.55896	1	0	0	metastatic	0.9	0.4	no dnr	9	79	8.5	76	36	40.5	null	null	0.599976	0.699951	136	null	122	4	4,450	null	0	null	0
1,013	32.616	1	female	0	4	119	CHF	COPD/CHF/Cirrhosis	1	12	$11-$25k	0	8,228	4,918.0547	4,392.89844	6	white	19.699219	25	0.930908	0.882935	1	0	0	no	0.7	0.7	no dnr	4	67	7.899414	120	26	37.5	null	null	null	1.299805	139	null	113	14	2,150	0	0	no(M2 and SIP pres)	0
1,014	78.48596	1	male	0	33	37	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	26	168,174	67,323	71,125.875	30.5	white	27.296875	27	0.524902	0.408997	5	0	0	no	0.9	0.8	no dnr	33	115	14	65	36	36.79688	320	null	null	0.5	125	7.55957	101	17	1,660	null	null	<2 mo. follow-up	3.276856
1,015	41.64798	1	female	0	6	568	Colon Cancer	Cancer	1	14	>$50k	0	16,011	7,885.75	8,819.71875	6	white	12.398438	13	0.897949	0.765991	1	0	0	metastatic	0.8	0.3	no dnr	6	77	null	76	22	37.69531	null	null	null	null	140	null	null	null	1,350	0	0	null	0
1,016	55.58398	1	female	0	110	208	MOSF w/Malig	ARF/MOSF	1	11	$11-$25k	0	null	null	null	50.5	white	41.5	62	0.075989	0.028	24	0	0	metastatic	0.5	0.5	null	null	130	19.5	125	24	37.59375	81.10938	1.699951	7.799805	0.699951	126	7.349609	188	22	6,865	null	null	SIP>=30	2.901856
1,017	64.32898	1	male	0	4	71	Lung Cancer	Cancer	1	12	under $11k	0	7,735	4,253.4219	5,050.82812	7	white	16.296875	19	0.723999	0.449951	1	0	0	metastatic	0.9	0.8	no dnr	4	69	14.298828	66	18	36.59375	null	null	null	1.199951	141	null	85	28	null	null	null	null	2.3125
1,018	77.77698	1	female	1	8	8	Coma	Coma	1	16	under $11k	89	63,572	26,724.9844	31,751.0781	41	white	34.5	69	0.011	0.004	1	1	0	no	0.2	0.15	dnr after sadm	7	52	6.699219	150	20	38.09375	164	3.099609	0.5	3.299805	132	7.379883	273	70	4,352	null	1	<2 mo. follow-up	1
1,019	82.98999	1	male	0	12	220	CHF	COPD/CHF/Cirrhosis	2	8	$11-$25k	0	51,711	26,562	33,344.6562	22	white	18.796875	29	0.817993	0.704956	1	0	0	no	0.8	0.7	no dnr	12	73	9.5	60	28	36.19531	null	3.899902	1	1.899902	139	null	113	32	4,750	0	0	no(M2 and SIP pres)	0
1,020	72.77496	1	female	0	9	103	CHF	COPD/CHF/Cirrhosis	5	12	under $11k	0	28,137	14,024.8984	12,920.5469	16.5	black	16.398438	16	0.845947	0.746948	1	0	0	yes	0.85	0.75	no dnr	9	115	5.099609	60	20	36.59375	null	null	0.799927	0.799927	135	null	120	17	1,170	3	4	adl>=4 (>=5 if sur)	4
1,021	70.04498	1	female	0	18	139	COPD	COPD/CHF/Cirrhosis	4	9	under $11k	26	119,685	45,163.6875	47,995.375	32.333313	black	21.199219	34	0.758911	0.61792	1	1	0	no	0.6	0.5	no dnr	18	112	14.398438	115	26	38	237.5	null	null	1.199951	148	7.349609	330	22	982	null	5	adl>=4 (>=5 if sur)	5
1,022	43.93198	0	male	0	9	914	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	under $11k	55	57,142	20,929.6562	21,162.0156	25	white	33.195313	39	0.488953	0.370972	2	0	0	no	0.9	0.9	no dnr	9	118	15.199219	95	40	38.5	111.65625	null	null	2.899902	151	7.15918	161	16	8,115	null	1	no(M2 and SIP pres)	1
1,023	70.61694	0	female	0	22	913	Coma	Coma	2	14	$25-$50k	44	75,372	34,204.4375	71,189.4375	19	white	17.796875	19	0.606934	0.542969	1	0	0	no	0.15	0.1	dnr after sadm	2	60	9.5	115	9	38	380	2.799805	0.5	0.699951	139	7.419922	150	5	1,940	null	7	null	7
1,024	38.07797	0	female	0	4	911	MOSF w/Malig	ARF/MOSF	1	16	$11-$25k	0	51,241	13,257.8125	8,457.69531	18	white	22.398438	28	0.660889	0.563965	4	0	0	metastatic	0.97	0.7	no dnr	4	67	9.398438	108	24	35.79688	410	2.199707	0.599976	1.399902	131	7.399414	104	37	2,850	null	null	null	2.429688
1,025	38.90997	1	female	0	5	232	Cirrhosis	COPD/CHF/Cirrhosis	4	11	null	0	19,379	9,072.9062	10,849.0078	23	white	22.296875	22	0.860962	0.769897	1	0	0	no	0.95	0.95	no dnr	5	72	6.5	75	24	37.59375	null	null	6.399414	0.299988	136	null	89	6	2,519	null	0	SIP>=30	0
1,026	27.29099	0	female	0	11	910	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	50,203	21,781.4844	21,434.4688	13	white	35.695313	51	0.764893	0.689941	1	0	0	no	0.75	0.75	no dnr	11	107	16.796875	125	35	39.39844	96	3.599609	0.299988	2.399902	144	7.429688	128	28	1,741	null	null	null	3.161621
1,027	20.85399	0	male	0	8	909	CHF	COPD/CHF/Cirrhosis	2	15	>$50k	0	20,579	11,638.5703	8,873.57812	9.5	hispanic	27.398438	35	0.901978	0.835938	1	0	0	no	0.8	0.7	no dnr	8	52	8.699219	125	16	36.09375	null	null	1	1.599854	137	null	92	30	2,825	0	0	no(M2 and SIP pres)	0
1,028	55.767	1	male	0	10	46	Lung Cancer	Cancer	1	12	null	0	30,453	12,746.4297	13,067.5625	18	white	37	45	0.201996	0.018997	1	0	0	metastatic	0.9	0.5	no dnr	10	52	14.798828	112	32	39.69531	null	2	0.699951	1.199951	132	null	85	19	1,630	null	null	<2 mo. follow-up	3.716309
1,029	42.09399	1	female	0	12	219	Lung Cancer	Cancer	1	12	under $11k	0	43,422	21,040.4531	19,418.4688	7.5	black	12	12	0.830933	0.631958	1	0	0	metastatic	0.95	0.6	no dnr	12	81	14	120	16	36.39844	null	4.199219	0.099991	1	139	null	97	7	2,220	2	3	null	3
1,030	78.81995	1	female	0	57	437	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	under $11k	26	436,904	161,974.25	329,348.75	30.75	white	30.398438	47	0.426941	0.306946	6	0	0	no	0.5	0.5	dnr after sadm	11	128	10.398438	120	12	37.59375	143.75	2.799805	null	2.699707	146	7.40918	62	58	4,600	null	6	null	6
1,031	65.74695	1	female	0	21	186	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	44	130,357	47,683.0625	58,079.3438	29.666656	white	34.09375	53	0.258972	0.153992	3	0	0	yes	0.8	0.3	no dnr	21	67	13.599609	55	8	38	105.09375	null	20.097656	1.299805	135	7.5	null	null	4,017	null	null	null	3.033691
1,032	50.01199	1	male	0	5	6	Lung Cancer	Cancer	2	16	>$50k	0	9,518	4,221.1719	4,356.33984	10	black	20.699219	26	0.668945	0.368958	1	0	0	metastatic	0.8	0.65	dnr after sadm	2	69	55	76	20	36.39844	null	null	null	0.699951	133	null	null	20	2,050	5	null	<2 mo. follow-up	3.854981
1,033	23.24699	1	male	1	23	23	MOSF w/Malig	ARF/MOSF	1	12	>$50k	0	419,195	115,365.25	102,054.688	36.333313	white	44.09375	97	0.127991	0.057999	19	0	0	yes	0.2	0.1	no dnr	23	67	0.049995	145	42	38.39844	144.875	null	8.699219	1.699951	145	7.289062	598	69	3,920	null	0	<2 mo. follow-up	0
1,034	38.418	0	male	0	34	905	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	null	26	257,291	null	null	22.5	white	23.5	28	0.803955	0.738892	5	0	0	no	null	null	no dnr	34	65	12.599609	55	16	39	160	null	null	0.799927	133	7.459961	102	20	2,745	null	null	null	2.799805
1,035	91.25299	1	female	0	6	440	CHF	COPD/CHF/Cirrhosis	2	14	null	0	23,547	9,465.8984	10,411.125	21	white	29.898438	40	0.55188	0.35498	1	0	0	no	0.9	0.8	no dnr	6	55	8.699219	50	16	36	236.71875	null	null	1.699951	125	7.139648	109	36	1,475	0	0	null	0
1,036	45.31097	1	male	0	11	93	Colon Cancer	Cancer	2	12	$11-$25k	0	32,838	14,494.5859	16,710.1719	14.5	white	14.898438	21	0.871948	0.712891	1	0	0	metastatic	0.8	0.5	no dnr	11	125	7.899414	74	22	38.5	null	null	2.399902	0.699951	140	null	111	10	1,800	0	1	null	1
1,037	49.16898	1	male	0	8	15	ARF/MOSF w/Sepsis	ARF/MOSF	8	13	$25-$50k	0	59,761	18,474.4688	19,510.7656	24	white	32.695313	58	0.707886	0.618896	2	1	0	no	null	null	dnr after sadm	2	55	14.798828	115	20	36.29688	479.5625	3.099609	null	6.799805	130	7.349609	null	43	0	5	3	<2 mo. follow-up	3
1,038	27.058	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	under $11k	0	194,402	76,774.375	190,487.75	52	white	55.195313	111	0.274963	0.166992	1	0	0	no	0.25	0.25	dnr after sadm	10	38	5.799805	165	14	35.5	118.75	2.899902	4.699219	5.5	148	7.089844	9	28	206	null	0	<2 mo. follow-up	0
1,039	65.99896	1	male	0	5	62	Colon Cancer	Cancer	1	18	$25-$50k	0	3,792	2,358.4785	2,450.26953	9	black	19.398438	17	0.779907	0.540894	1	0	0	metastatic	0.25	0.05	no dnr	5	77	6.299805	64	24	36.39844	null	3.799805	1.399902	1.299805	124	null	121	15	1,935	0	null	null	0.494751
1,040	70.03699	1	female	0	9	36	Lung Cancer	Cancer	2	14	under $11k	0	14,609	7,164.4805	6,895.14844	8.5	black	28.699219	26	0.392944	0.098999	1	1	0	metastatic	0.2	0	dnr after sadm	1	73	10.699219	136	32	39.09375	null	null	null	0.599976	126	null	162	8	2,200	3	5	<2 mo. follow-up	5
1,041	60.504	1	male	1	8	8	Cirrhosis	COPD/CHF/Cirrhosis	3	13	under $11k	0	49,985	25,018.3438	23,997.1562	36	white	33	60	0.50293	0.301941	1	0	0	no	0.3	0.15	dnr after sadm	8	62	15.199219	60	22	36.39844	null	2.399902	19.796875	3.399902	145	null	188	131	700	null	null	<2 mo. follow-up	3.048828
1,042	29.53299	1	male	0	28	102	MOSF w/Malig	ARF/MOSF	1	17	under $11k	0	102,427	46,724	48,618.5625	17.5	black	21.597656	12	0.767944	0.69397	2	0	0	yes	0.9	0.6	no dnr	28	81	5.599609	125	22	36.79688	null	null	null	1.299805	138	null	null	12	3,000	0	null	null	0.494751
1,043	53.07599	0	female	0	7	892	CHF	COPD/CHF/Cirrhosis	4	16	>$50k	0	29,187	13,135.7578	14,763.3984	17	hispanic	22.398438	21	0.797974	0.674927	1	0	0	metastatic	0.8	0.6	no dnr	7	55	8.699219	100	18	36	null	null	1.5	0.799927	135	null	86	10	2,080	1	4	adl>=4 (>=5 if sur)	4
1,044	67.784	1	female	1	51	51	ARF/MOSF w/Sepsis	ARF/MOSF	1	18	null	41	411,846	147,752.125	165,394.125	38.25	white	17.398438	32	0.741943	0.660889	6	0	0	no	0.9	0.9	dnr after sadm	49	65	17.199219	65	8	37.69531	351	2.699707	3.099609	1.099854	139	7.55957	94	9	1,625	null	2	<2 mo. follow-up	2
1,045	53.26199	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	>$50k	0	203,408	78,476.3125	208,533.75	62	white	42.195313	86	0.473999	0.355957	1	0	0	no	0.3	0.3	dnr after sadm	7	72	5.299805	125	12	35.39844	85	2.899902	12.099609	1.599854	143	7.419922	332	66	140	null	5	<2 mo. follow-up	5
1,046	59.17599	1	female	1	5	5	Coma	Coma	0	15	$25-$50k	100	31,803	13,809.9688	15,185.8594	32	white	20.796875	55	0.355957	0.282959	1	0	0	no	0.1	0.1	dnr after sadm	3	141	1.299805	125	32	38.59375	207.5	2.099609	0.599976	0.699951	137	7.519531	207	27	1,448	null	0	<2 mo. follow-up	0
1,047	47.21997	1	male	0	7	426	CHF	COPD/CHF/Cirrhosis	4	14	under $11k	0	14,827	8,235.9219	6,062.54688	7.5	white	15.699219	23	0.931885	0.883911	1	1	0	no	0.85	0.8	no dnr	7	75	5.899414	75	32	37.5	null	null	null	1.5	138	null	102	19	2,100	4	3	adl>=4 (>=5 if sur)	3
1,048	54.021	1	male	0	4	116	Lung Cancer	Cancer	2	null	null	0	6,533	3,276.0098	3,331.62891	14	white	15.599609	24	0.758911	0.504883	1	0	0	metastatic	0.5	0.5	no dnr	4	65	3.899902	56	12	38	null	null	0.299988	0.899902	140	null	null	13	1,225	null	null	null	2.495606
1,049	81.25397	1	female	0	12	62	Lung Cancer	Cancer	1	12	$11-$25k	0	15,945	8,343.2969	9,195.6875	4	white	15	8	0.709961	0.428955	1	0	0	metastatic	0.4	0.05	dnr after sadm	1	81	null	76	28	36.59375	null	null	null	null	140	null	null	null	2,800	3	4	adl>=4 (>=5 if sur)	4
1,050	91.43896	0	female	0	18	883	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	>$50k	61	68,103	31,396.25	32,957.5	25.666656	white	16.5	46	0.626953	0.522949	1	0	0	no	0.4	0.1	dnr after sadm	7	75	9.5	75	37	36.5	562.75	2.099609	0.5	1.099854	134	7.599609	202	24	670	null	6	adl>=4 (>=5 if sur)	6
1,051	65.31696	1	male	0	3	312	ARF/MOSF w/Sepsis	ARF/MOSF	3	16	>$50k	37	80,470	10,313.6797	12,423.3125	33	white	26.699219	64	0.582886	0.472961	4	1	0	no	0.5	0.25	no dnr	3	65	12	65	22	37.59375	134.53125	2.299805	null	9.398438	132	7.389648	322	103	0	null	2	null	2
1,052	48.94998	0	female	0	5	881	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	12,684	6,731.8086	6,553.53906	17	hispanic	19.398438	7	0.905884	0.840942	1	0	0	no	0.95	0.95	no dnr	5	107	6.899414	105	22	36	null	null	null	0.799927	136	null	105	12	2,470	0	null	no(M2 and SIP pres)	0.494751
1,053	54.853	1	male	0	37	174	ARF/MOSF w/Sepsis	ARF/MOSF	4	null	null	26	272,366	77,111.5625	117,935.188	37.25	white	27.398438	46	0.639893	0.537964	10	0	0	no	null	null	no dnr	37	72	8.5	125	26	39.39844	174	null	3	1.699951	142	7.489258	122	32	3,411	null	null	null	3.483887
1,054	75.16797	1	female	0	11	26	MOSF w/Malig	ARF/MOSF	2	14	$25-$50k	0	31,213	14,603.8047	16,043.125	18	asian	27.898438	30	0.513916	0.396973	1	1	0	metastatic	0.15	0.1	dnr after sadm	2	109	14.199219	125	14	36.29688	357.125	null	null	1.099854	125	7.479492	342	15	1,656	null	4	<2 mo. follow-up	4
1,055	70.16296	0	male	0	27	879	CHF	COPD/CHF/Cirrhosis	2	16	$25-$50k	0	159,568	92,464.625	77,863.1875	19.25	white	26.5	34	0.75293	0.609985	1	0	0	no	0.7	0.5	no dnr	27	53	5.5	105	18	36.5	null	null	null	2.099609	134	null	107	29	3,490	0	0	no(M2 and SIP pres)	0
1,056	91.08795	1	female	0	10	387	ARF/MOSF w/Sepsis	ARF/MOSF	1	20	>$50k	9	34,662	18,039.8906	18,089.8281	13	white	19.796875	27	0.751953	0.672974	1	0	0	no	0.6	0.5	dnr after sadm	1	110	11.798828	105	33	38	330	null	null	0.899902	145	7.589844	220	11	650	null	0	null	0
1,057	50.76797	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	2	19	>$50k	0	312,860	36,578.3438	35,032.4375	39	white	42.695313	97	0.333984	0.218994	47	0	0	no	0	0	dnr after sadm	2	58	11.398438	70	35	36.79688	109.07812	2.199707	19.796875	3.699707	148	7.609375	206	50	0	null	0	<2 mo. follow-up	0
1,058	29.77399	0	male	0	36	878	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$25-$50k	44	333,521	151,389.25	165,328.875	33	white	37.796875	77	0.449951	0.329956	7	0	0	no	0.35	0.35	no dnr	36	65	25.296875	120	45	36.89844	168	2.199707	7.099609	1.799805	155	7.479492	184	53	1,665	null	0	no(M2 and SIP pres)	0
1,059	63.37	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	5	11	null	94	65,661	26,997.4688	29,392.3125	66	hispanic	51.898438	88	0	0	2	1	0	no	0.5	0.5	dnr after sadm	5	55	6.199219	55	24	36	80	3.299805	42	4.599609	145	7.199219	347	56	105	null	7	<2 mo. follow-up	7
1,060	38.80399	1	female	1	16	16	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	44	407,955	125,929.75	132,617.125	47	hispanic	34.296875	57	0.474976	0.356995	10	0	0	no	0.4	0.4	dnr after sadm	15	70	1.399902	65	30	36.39844	287.5	2.399902	24.296875	1.299805	141	7.40918	167	51	1,713	null	5	<2 mo. follow-up	5
1,061	77.50598	1	female	0	7	13	COPD	COPD/CHF/Cirrhosis	4	null	null	0	32,303	13,342.4531	13,298.7656	10	white	16.699219	26	0.841919	0.740967	1	0	0	no	0.5	0.2	dnr before sadm	-1	70	11.298828	68	22	37.5	250	null	1.299805	0.699951	145	7.429688	null	23	810	null	null	<2 mo. follow-up	4.378906
1,062	65.90796	1	female	0	6	115	Colon Cancer	Cancer	1	17	>$50k	0	9,327	5,024.7109	5,283.13672	13	white	17.5	5	0.80896	0.591919	1	0	0	metastatic	0.9	0.6	no dnr	6	85	9.199219	82	20	36.59375	null	3.199707	0.599976	0.799927	139	null	null	9	null	null	null	no(M2 and SIP pres)	1.984375
1,063	23.84399	1	female	0	29	105	MOSF w/Malig	ARF/MOSF	1	15	$11-$25k	0	215,913	73,125.5	81,951.375	25	hispanic	28.199219	37	0.601929	0.494995	6	0	0	yes	0.8	0.7	no dnr	29	82	0.049995	150	24	38.39844	null	null	null	0.799927	137	null	null	6	2,250	null	0	no(M2 and SIP pres)	0
1,064	58.724	1	male	1	19	19	ARF/MOSF w/Sepsis	ARF/MOSF	2	20	>$50k	41	461,154	180,363.75	168,425.75	51.666657	white	37.898438	104	0.27594	0.167999	5	0	0	no	0.5	0.5	dnr after sadm	19	58	9.898438	115	26	39	116	2.799805	8.5	2.099609	139	7.149414	71	55	160	null	0	<2 mo. follow-up	0
1,065	79.71497	0	female	0	24	870	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	>$50k	26	241,269	55,635.25	56,483.1562	35	white	21.898438	42	0.541992	0.426941	16	0	0	yes	0.75	0.7	no dnr	24	58	12.699219	75	30	36.39844	268	2.699707	0.299988	1.599854	132	7.419922	164	30	3,510	null	0	no(M2 and SIP pres)	0
1,066	48.81897	1	male	1	5	5	Lung Cancer	Cancer	1	16	null	26	14,258	7,296.1016	8,209.88281	20	black	27.097656	27	0.377991	0.089996	1	0	0	metastatic	0	0	dnr after sadm	3	101	6.599609	146	22	38.39844	120.40625	3.199707	0.199982	0.899902	141	7.429688	144	19	2,600	null	4	<2 mo. follow-up	4
1,067	41.98798	0	male	0	16	866	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	>$50k	37	501,348	63,796.875	59,837.3125	39	white	27.898438	66	0.632935	0.529907	27	0	0	no	0.6	0.6	no dnr	16	58	11.898438	135	10	38.69531	252.5	4.699219	1.099854	6.099609	139	7.40918	247	90	0	null	0	SIP>=30	0
1,068	79.04199	1	male	1	17	17	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	null	44	274,616	73,806.375	74,751.75	44	white	33.296875	54	0.225983	0.126984	10	0	0	no	0.1	0.1	dnr after sadm	9	62	12.199219	115	14	38.39844	105	null	11.298828	1.199951	138	7.449219	201	32	1,925	null	0	<2 mo. follow-up	0
1,069	44.616	0	male	0	16	866	CHF	COPD/CHF/Cirrhosis	2	16	under $11k	0	71,501	34,153.9062	38,849.9375	25	white	42.09375	28	0.565918	0.370972	1	0	0	no	0.8	0.6	no dnr	16	42	7.5	105	14	36	null	3	3.199707	1.099854	126	null	106	19	2,625	4	5	null	5
1,070	24.21899	1	male	1	3	3	MOSF w/Malig	ARF/MOSF	1	13	null	55	106,744	14,836.7031	16,656.7656	31	black	72.1875	91	0	0	22	0	0	yes	0.02	0	dnr after sadm	2	5	5.099609	0	35	36.09375	420	null	null	4.899414	138	7.069336	null	47	88	null	0	<2 mo. follow-up	0
1,071	66.146	1	male	1	7	7	CHF	COPD/CHF/Cirrhosis	3	17	$25-$50k	0	44,384	19,614.8125	22,711.1094	40	white	31.699219	47	0.67395	0.50293	1	0	0	no	null	null	no dnr	7	52	9.898438	65	16	36	null	3.399902	1.799805	1.899902	126	null	204	51	650	0	0	<2 mo. follow-up	0
1,072	58.53	0	female	0	5	864	CHF	COPD/CHF/Cirrhosis	2	null	null	0	8,325	4,990.1484	4,167.06641	18	asian	25.898438	46	0.810913	0.694946	1	0	0	no	0.8	0.7	no dnr	5	53	6.799805	115	20	36.39844	null	3.899902	2.199707	2	136	null	171	49	4,050	null	1	null	1
1,073	41.54999	0	male	0	8	864	CHF	COPD/CHF/Cirrhosis	3	21	under $11k	0	31,741	15,434.2344	16,267.9141	14	white	21.597656	24	0.903931	0.838989	1	0	0	no	0.8	0.7	no dnr	8	55	6.899414	115	16	36	null	3.599609	1.299805	1.199951	132	null	88	13	3,300	0	null	no(M2 and SIP pres)	0.494751
1,074	75.146	1	female	0	8	746	Colon Cancer	Cancer	1	null	null	0	22,930	10,770.4922	11,152.2422	10	white	11.199219	16	0.868896	0.704956	1	0	0	metastatic	null	null	no dnr	8	72	10.398438	84	20	37.79688	null	3.799805	0.399963	0.699951	136	null	147	7	1,025	null	null	null	2.500488
1,075	21.922	0	male	0	37	864	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	407,547	133,430.75	129,080.562	44	hispanic	24.597656	45	0.882935	0.840942	7	0	0	no	0.5	0.5	no dnr	37	67	15.398438	140	16	38	162.5	null	0.299988	0.799927	135	7.5	194	39	4,920	null	null	no(M2 and SIP pres)	2.060547
1,076	58.09998	1	female	1	4	4	MOSF w/Malig	ARF/MOSF	2	null	null	55	197,978	16,211.4844	17,017.625	33	white	53.695313	116	0	0	35	1	0	yes	0.1	0.05	dnr after sadm	2	37	0.199982	115	4	36.79688	310	null	5.599609	1.899902	139	7.219727	211	74	114	null	null	<2 mo. follow-up	2.914551
1,077	89.77997	1	male	1	3	3	Coma	Coma	2	null	null	100	19,078	8,106.625	10,791.7031	28	white	15.5	31	0.201996	0.140991	1	0	1	no	null	null	dnr after sadm	1	78	17.296875	80	9	38.5	237.5	null	null	1.199951	149	7.449219	107	39	350	null	null	<2 mo. follow-up	5.645508
1,078	60.61298	1	male	0	12	754	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	42,604	23,808.5781	25,027.375	16.5	hispanic	18.597656	38	0.886963	0.810913	1	0	0	no	0.8	0.6	no dnr	12	55	5.799805	45	16	36.19531	null	4.199219	0.5	1.599854	133	null	119	25	2,770	0	0	no(M2 and SIP pres)	0
1,079	52.87097	0	male	0	54	861	ARF/MOSF w/Sepsis	ARF/MOSF	3	11	$25-$50k	26	509,887	150,755.75	138,829.5	42.75	white	25	57	0.700928	0.611938	10	0	0	no	0.6	0.6	no dnr	54	125	7.899414	105	42	38	null	2.399902	9	0.699951	135	null	184	45	2,080	null	2	adl>=4 (>=5 if sur)	2
1,080	94.55194	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	$11-$25k	0	40,533	16,502.4688	18,087.75	43	white	61.296875	83	0	0	1	0	0	no	0	0	dnr after sadm	3	13	11.099609	45	8	35.59375	202.5	3.299805	3.199707	2	147	7.329102	205	49	360	null	0	<2 mo. follow-up	0
1,081	29.53	0	female	0	32	852	ARF/MOSF w/Sepsis	ARF/MOSF	1	15	$11-$25k	0	89,501	37,115	33,926.4375	8.75	asian	21.296875	42	0.916992	0.886963	1	0	0	no	1	1	no dnr	32	65	28.199219	74	22	36.59375	612	1.099854	null	1.399902	127	7.399414	158	38	600	0	0	SIP>=30	0
1,082	75.10999	1	male	0	4	49	Lung Cancer	Cancer	2	14	$25-$50k	0	8,323	4,449.6875	4,317.80859	15	asian	27.597656	42	0.407959	0.108994	1	0	0	metastatic	0.5	0.15	dnr before sadm	-1	73	8.298828	128	30	35.59375	null	null	null	2.099609	135	null	152	31	1,475	2	null	<2 mo. follow-up	1.838867
1,083	83.13495	1	male	0	15	95	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	47,079	21,050.375	20,225.4844	14.666664	hispanic	31.597656	48	0.461975	0.34198	2	0	0	yes	0.2	0.05	dnr after sadm	2	103	25.898438	130	20	39.5	372	2.399902	21.796875	1.399902	140	7.419922	null	27	2,900	null	null	null	3.766113
1,084	38.93799	1	male	1	53	53	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	26	1,045,982	211,981.5	213,677.5	47.25	hispanic	26.597656	51	0.706909	0.61792	115	0	0	no	0.5	0.3	dnr after sadm	51	78	3.299805	140	48	38.79688	212.5	1.799805	0.399963	1.099854	146	7.369141	150	24	3,970	null	6	<2 mo. follow-up	6
1,085	61.70599	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	3	10	under $11k	26	60,681	23,473.4219	29,124.5156	32	white	42.796875	102	0.261963	0.155975	1	0	0	no	0.8	0.7	dnr after sadm	6	58	15.5	165	38	38.59375	162.5	null	13.099609	4.699219	149	7.619141	94	86	70	null	5	<2 mo. follow-up	5
1,086	49.32199	1	female	0	15	130	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	>$50k	0	193,938	33,939.4688	32,411.4844	24.333328	white	30.199219	48	0.701904	0.611938	12	0	0	no	0.9	0.8	no dnr	15	56	5.199219	130	32	36.39844	null	null	null	1.899902	135	null	null	58	3,210	0	0	no(M2 and SIP pres)	0
1,087	72.26794	0	male	0	19	848	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	$25-$50k	0	77,088	32,681.6719	33,255.2188	27	white	24.199219	35	0.726929	0.642944	1	0	0	yes	0.9	0.9	no dnr	19	68	7.699219	55	24	36.59375	202.84375	3.199707	0.299988	2.599609	130	7.509766	null	55	2,608	null	1	no(M2 and SIP pres)	1
1,088	59.81897	0	female	0	4	846	CHF	COPD/CHF/Cirrhosis	0	11	$25-$50k	0	12,972	5,645.2266	5,480.20703	18	black	18	22	0.893921	0.821899	1	0	0	no	0.9	0.8	no dnr	4	84	16.796875	66	26	36.79688	323.75	null	null	1.299805	139	7.389648	107	26	4,000	null	0	null	0
1,089	79.98895	0	male	0	6	846	COPD	COPD/CHF/Cirrhosis	2	13	$25-$50k	0	17,986	7,659.9102	6,822.23828	20	black	25.199219	41	0.688965	0.522949	1	0	0	no	0.7	0.7	no dnr	6	74	3.799805	102	20	37.59375	195.21875	2.899902	0.399963	2.399902	141	7.30957	86	30	4,820	0	null	SIP>=30	0.494751
1,090	67.35699	1	male	0	8	627	CHF	COPD/CHF/Cirrhosis	3	20	>$50k	0	36,549	17,240.5625	17,851.75	25.5	white	24.796875	33	0.792969	0.666992	1	0	0	no	0.55	0.4	no dnr	8	58	9.699219	95	14	36.09375	null	3.099609	0.799927	1.5	130	null	108	24	3,100	4	null	no(M2 and SIP pres)	3.183106
1,091	70.29199	0	female	0	9	844	CHF	COPD/CHF/Cirrhosis	4	13	under $11k	0	22,123	13,162.875	11,510.5469	8	black	19.097656	18	0.855957	0.761963	1	1	0	no	0.8	0.7	no dnr	9	103	7.299805	115	24	37	null	3.299805	1.099854	1.099854	140	null	135	15	1,970	2	0	SIP>=30	0
1,092	77.42096	1	female	1	3	3	Coma	Coma	0	null	null	100	93,782	9,460.7344	9,443.10938	30	white	38.695313	55	0	0	18	0	0	no	0	0	dnr before sadm	0	72	41.5	80	14	35.5	122.5	null	0.099991	0.399963	119	7.599609	127	27	84	null	null	<2 mo. follow-up	3.126953
1,093	82.29395	1	male	0	6	529	Coma	Coma	2	null	null	44	39,770	16,190.4453	19,527.0469	26	white	20	51	0.406982	0.332947	2	1	0	no	0.5	0.5	no dnr	6	62	21.5	65	50	38.29688	271.375	2.199707	null	1.199951	147	7.429688	215	30	1,590	null	null	null	2.861816
1,094	56.02698	1	male	0	18	295	CHF	COPD/CHF/Cirrhosis	3	14	$11-$25k	0	32,470	20,180.0156	14,304.4688	13	white	24	24	0.844971	0.744995	1	1	0	no	0.95	0.9	no dnr	18	90	10.099609	120	20	36.79688	null	3.799805	null	3.299805	141	null	105	37	4,130	1	null	SIP>=30	1.166748
1,095	64.88397	1	male	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	4	14	$25-$50k	0	221,993	45,616.8125	47,116.8125	30.5	white	35.898438	55	0.467957	0.348999	12	1	0	no	0.6	0.5	no dnr	13	48	15.699219	95	22	36.79688	null	null	null	3.099609	127	null	null	60	100	null	5	<2 mo. follow-up	5
1,096	33.60699	0	male	0	18	842	Coma	Coma	0	16	>$50k	100	53,325	25,504.8125	43,346.9375	16	asian	23.296875	37	0.541992	0.472961	1	0	0	no	0.5	0.3	no dnr	18	135	18.097656	150	9	38.59375	427.5	4.099609	0.699951	0.899902	133	7.429688	144	15	1,305	null	0	no(M2 and SIP pres)	0
1,097	88.91199	0	female	0	11	841	Coma	Coma	2	17	$25-$50k	41	43,891	17,630.4688	18,825.7969	17	black	22.699219	39	0.240997	0.175995	4	0	1	no	0.5	0.25	no dnr	11	131	15.099609	150	8	38	371.375	null	null	0.899902	134	7.399414	null	12	1,830	null	5	adl>=4 (>=5 if sur)	5
1,098	54.81198	0	male	0	54	840	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	653,743	92,126.8125	73,470.125	21.5	black	20.296875	37	0.823975	0.763916	80	1	0	no	0.95	0.95	no dnr	54	111	24.5	60	10	36.69531	520	2.099609	0.199982	0.799927	133	7.299805	194	34	3,080	null	0	no(M2 and SIP pres)	0
1,099	66.49396	0	male	0	7	839	Colon Cancer	Cancer	1	null	null	0	28,819	12,945.9062	15,484.7188	11.5	white	23.597656	13	0.703979	0.417969	1	0	0	metastatic	1	0.9	no dnr	7	99	null	100	22	38	136.71875	null	null	1.099854	129	7.459961	null	11	2,640	null	null	null	2.890625
1,100	52.22198	1	male	0	16	84	MOSF w/Malig	ARF/MOSF	1	14	under $11k	0	73,669	32,506.2969	32,569.6719	19	asian	24.5	29	0.704956	0.615967	1	0	0	yes	0.8	0.5	no dnr	16	78	5.599609	115	30	38.29688	614.25	null	1.299805	1.099854	128	7.479492	145	24	2,260	null	1	adl>=4 (>=5 if sur)	1

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.